8.19
price up icon5.27%   0.41
after-market アフターアワーズ: 8.12 -0.07 -0.85%
loading
前日終値:
$7.78
開ける:
$7.74
24時間の取引高:
574.57K
Relative Volume:
1.42
時価総額:
$151.74M
収益:
$1.54M
当期純損益:
$-84.53M
株価収益率:
-1.4085
EPS:
-5.8145
ネットキャッシュフロー:
$-73.65M
1週間 パフォーマンス:
+8.33%
1か月 パフォーマンス:
-28.35%
6か月 パフォーマンス:
-15.57%
1年 パフォーマンス:
-10.69%
1日の値動き範囲:
Value
$7.74
$8.325
1週間の範囲:
Value
$7.4501
$8.325
52週間の値動き範囲:
Value
$6.72
$20.56

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Company Profile

Name
名前
Corbus Pharmaceuticals Holdings Inc
Name
セクター
Healthcare (1109)
Name
電話
617-963-0103
Name
住所
500 RIVER RIDGE DRIVE, NORWOOD, MA
Name
職員
36
Name
Twitter
@corbuspharma
Name
次回の収益日
2026-08-04
Name
最新のSEC提出書
Name
CRBP's Discussions on Twitter

Compare CRBP vs VRTX, REGN, ARGX, ALNY, RVMD

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
CRBP icon
CRBP
Corbus Pharmaceuticals Holdings Inc
8.19 144.15M 1.54M -84.53M -73.65M -5.8145
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
444.93 112.95B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
612.14 64.11B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
893.52 55.90B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
282.85 38.64B 4.29B 577.22M 641.34M 4.2086
RVMD icon
RVMD
Revolution Medicines Inc
153.87 31.73B 742.00K -1.37B -1.07B -7.0731

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-30 再開されました B. Riley Securities Buy
2025-02-28 開始されました William Blair Outperform
2024-12-02 開始されました Piper Sandler Overweight
2024-07-30 開始されました Wedbush Outperform
2024-07-22 再開されました H.C. Wainwright Buy
2024-06-26 開始されました B. Riley Securities Buy
2024-06-03 繰り返されました Oppenheimer Outperform
2024-05-13 開始されました RBC Capital Mkts Outperform
2024-03-06 アップグレード Jefferies Hold → Buy
2020-09-08 ダウングレード BTIG Research Buy → Neutral
2020-09-08 ダウングレード Jefferies Buy → Hold
2020-09-08 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2020-09-08 ダウングレード ROTH Capital Buy → Neutral
2020-07-07 開始されました ROTH Capital Buy
2020-06-17 開始されました BTIG Research Buy
2020-03-26 開始されました Nomura Buy
2019-04-05 開始されました Jefferies Buy
2019-03-20 開始されました Oppenheimer Outperform
2019-01-11 繰り返されました Cantor Fitzgerald Overweight
2018-12-26 開始されました H.C. Wainwright Buy
2018-12-07 開始されました RBC Capital Mkts Outperform
2018-10-24 開始されました B. Riley FBR Buy
2018-01-19 開始されました Raymond James Outperform
2017-12-14 繰り返されました Cantor Fitzgerald Overweight
2017-11-08 繰り返されました Noble Financial Buy
2017-09-29 再開されました Noble Financial Buy
2017-03-30 繰り返されました Cantor Fitzgerald Overweight
2016-11-15 繰り返されました JMP Securities Mkt Outperform
2016-11-11 繰り返されました Noble Financial Buy
すべてを表示

Corbus Pharmaceuticals Holdings Inc (CRBP) 最新ニュース

pulisher
Jun 11, 2026

Corbus Pharmaceuticals Holdings Inc. stock rises Thursday, still underperforms market - MarketWatch

Jun 11, 2026
pulisher
Jun 11, 2026

Corbus Pharmaceuticals (CRBP) director sells 2,026 shares under 10b5-1 plan - Stock Titan

Jun 11, 2026
pulisher
Jun 11, 2026

Corbus (NASDAQ: CRBP) director sells 2,412 shares under 10b5-1 plan - Stock Titan

Jun 11, 2026
pulisher
Jun 11, 2026

Corbus (CRBP) director Jenkins sells 4,800 shares in Rule 10b5-1 trade - Stock Titan

Jun 11, 2026
pulisher
Jun 10, 2026

Corbus Pharmaceuticals teases cancer, obesity data as key clinical readouts near - MSN

Jun 10, 2026
pulisher
Jun 09, 2026

Corbus Pharmaceuticals Holdings Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch

Jun 09, 2026
pulisher
Jun 09, 2026

Corbus Pharmaceuticals targets HPV-linked head and neck cancer with CRB-701 study - MSN

Jun 09, 2026
pulisher
Jun 09, 2026

Corbus Pharmaceuticals Teases Cancer, Obesity Data as Key Clinical Readouts Near - Yahoo Finance

Jun 09, 2026
pulisher
Jun 08, 2026

Liquidity Mapping Around (CRBP) Price Events - Stock Traders Daily

Jun 08, 2026
pulisher
Jun 08, 2026

Insider Spends US$101k Buying More Shares In Corbus Pharmaceuticals Holdings - simplywall.st

Jun 08, 2026
pulisher
Jun 05, 2026

Corbus Pharmaceuticals Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch

Jun 05, 2026
pulisher
Jun 04, 2026

CRBP: Lead oncology and obesity assets advance with pivotal data and strong financial runway - TradingView

Jun 04, 2026
pulisher
Jun 04, 2026

Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch

Jun 04, 2026
pulisher
Jun 04, 2026

symbol__ Stock Quote Price and Forecast - CNN

Jun 04, 2026
pulisher
Jun 04, 2026

CRBP Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Jun 04, 2026
pulisher
Jun 03, 2026

Corbus Pharmaceuticals CBO Nishant Saxena buys $101,218 in stock By Investing.com - Investing.com Australia

Jun 03, 2026
pulisher
Jun 03, 2026

Corbus Pharmaceuticals CBO Nishant Saxena buys $101,218 in stock - Investing.com

Jun 03, 2026
pulisher
Jun 03, 2026

Corbus (CRBP) Chief Business Officer buys 13,500 shares in open market - Stock Titan

Jun 03, 2026
pulisher
Jun 03, 2026

Corbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Jun 03, 2026
pulisher
Jun 03, 2026

Oppenheimer Maintains Corbus Pharmaceuticals(CRBP.US) With Buy Rating, Maintains Target Price $54 - Moomoo

Jun 03, 2026
pulisher
Jun 02, 2026

Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch

Jun 02, 2026
pulisher
Jun 02, 2026

A Quick Look at Today's Ratings for Corbus Pharmaceuticals(CRBP.US), With a Forecast Between $40 to $54 - Moomoo

Jun 02, 2026
pulisher
Jun 01, 2026

Corbus Pharmaceuticals Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch

Jun 01, 2026
pulisher
Jun 01, 2026

Corbus Pharmaceuticals Targets HPV-Linked Head and Neck Cancer With CRB-701 Study - Yahoo Finance

Jun 01, 2026
pulisher
Jun 01, 2026

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Stock Price Today & Analysis - Gotrade

Jun 01, 2026
pulisher
May 29, 2026

CRBP Q1 2026 Earnings: Narrower Loss Misses on Thin Volume; No Revenue YetWeak Earnings Momentum - thelegaladvocate.com

May 29, 2026
pulisher
May 28, 2026

Corbus Pharmaceuticals Holdings Inc. stock underperforms Thursday when compared to competitors - MarketWatch

May 28, 2026
pulisher
May 28, 2026

Analysts Are Bullish on Top Healthcare Stocks: Eli Lilly & Co (LLY), Corbus Pharmaceuticals (CRBP) - The Globe and Mail

May 28, 2026
pulisher
May 28, 2026

Why (CRBP) Price Action Is Critical for Tactical Trading - Stock Traders Daily

May 28, 2026
pulisher
May 27, 2026

RBC Capital Maintains Corbus Pharmaceuticals(CRBP.US) With Buy Rating, Cuts Target Price to $36 - Moomoo

May 27, 2026
pulisher
May 27, 2026

TNXP Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

May 27, 2026
pulisher
May 27, 2026

CRBP Maintained by Wedbush -- Price Target Lowered to $30 - GuruFocus

May 27, 2026
pulisher
May 27, 2026

Mizuho Securities Maintains Corbus Pharmaceuticals(CRBP.US) With Buy Rating, Maintains Target Price $44 - Moomoo

May 27, 2026
pulisher
May 27, 2026

Corbus Pharmaceuticals: I'd Preach Caution After Selloff On Latest Data Drop (NASDAQ:CRBP) - Seeking Alpha

May 27, 2026
pulisher
May 27, 2026

LifeSci Capital Maintains Corbus Pharmaceuticals(CRBP.US) With Buy Rating, Maintains Target Price $38 - Moomoo

May 27, 2026
pulisher
May 27, 2026

Wedbush Maintains Corbus Pharmaceuticals(CRBP.US) With Buy Rating, Cuts Target Price to $30 - Moomoo

May 27, 2026
pulisher
May 26, 2026

Corbus Pharmaceuticals Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

May 26, 2026
pulisher
May 26, 2026

Corbus Pharmaceuticals Falls on Reports of Adverse Events in Tumor-Treatment Study - Moomoo

May 26, 2026
pulisher
May 26, 2026

Corbus Pharmaceuticals (CRBP) Analyst Sees Mispriced Weakness - GuruFocus

May 26, 2026
pulisher
May 26, 2026

Corbus Pharmaceuticals (CRBP) Reports Promising Data on CRB-701 Trial - GuruFocus

May 26, 2026
pulisher
May 26, 2026

Corbus Pharmaceuticals Stock (CRBP) Opinions on Updated CRB-701 Cancer Data Release - Quiver Quantitative

May 26, 2026
pulisher
May 26, 2026

CRBP Reiterated by HC Wainwright & Co. -- Price Target Maintained at $40 - GuruFocus

May 26, 2026
pulisher
May 26, 2026

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

May 26, 2026
pulisher
May 26, 2026

CRB-701 Phase 1/2 data outlines next steps, Corbus Pharmaceuticals Holdings, Inc. - Traders Union

May 26, 2026
pulisher
May 26, 2026

Corbus Pharma (CRBP) Faces Premarket Decline Following Phase 1/2 Trial Data - GuruFocus

May 26, 2026
pulisher
May 26, 2026

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Discusses Clinical Data Update From Phase 1/2 Study of CRB-701 Presented at ASCOSlideshow (NASDAQ:CRBP) 2026-05-26 - Seeking Alpha

May 26, 2026
pulisher
May 26, 2026

Corbus Pharmaceuticals stock falls on trial data release By Investing.com - Investing.com South Africa

May 26, 2026
pulisher
May 26, 2026

Corbus Pharmaceuticals stock falls on trial data release - Investing.com

May 26, 2026
pulisher
May 26, 2026

CRB-701 data advances Corbus (NASDAQ: CRBP) OPSCC and cervical plans - Stock Titan

May 26, 2026

Corbus Pharmaceuticals Holdings Inc (CRBP) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$30.04
price up icon 1.04%
$108.53
price up icon 0.65%
$90.54
price up icon 1.12%
$54.87
price down icon 0.76%
ONC ONC
$264.48
price up icon 1.62%
$153.87
price up icon 3.11%
大文字化:     |  ボリューム (24 時間):